Draft Chinese Medicine Law is expected to be approved by the State Council

Zhang Boli, deputy to the National People's Congress and dean of the China Academy of Chinese Medical Sciences, revealed that the Chinese Medicine Law will be approved by the State Council's executive meeting in July and then submitted to the Standing Committee of the National People's Congress for consideration. According to the conventional law, the draft law must be approved by the third reading. Zhang Bolui expects that the Chinese Medicine Law will complete the first reading by the Standing Committee of the National People's Congress before December 31 this year.

After 30 years of waiting, the legislative process of Chinese medicine is expected to make a breakthrough in the near future. According to a report by the China Securities Network, Zhang Boli, deputy to the National People's Congress and dean of the China Academy of Chinese Medical Sciences, revealed that the Chinese Medicine Law will be approved by the State Council’s executive meeting in July and then submitted to the Standing Committee of the National People's Congress for consideration. According to the conventional law, the draft law must be approved by the third reading. Zhang Bolui expects that the Chinese Medicine Law will complete the first reading by the Standing Committee of the National People's Congress before December 31 this year. With the determination of industrial policies and quality management standards in the form of laws, leading enterprises in the Chinese medicine industry are expected to benefit from the trend of standardized management and scale development.

“At present, more and more countries have implemented the legislative management of traditional medicine and formulated and promulgated laws and regulations concerning the management of traditional Chinese medicine. As a traditional Chinese medicine giant and origin, China still lacks legal protection at the national level.” NPC Standing Committee Vice Chairman Chen Hao pointed out at the first Huanghuang Forum held on June 30 that the Chinese medicine industry urgently needs to speed up the legislative process. Hundreds of representatives from scientific research, production, and competent departments attended the meeting. When Chen Yu said: “The good news is that when the draft of the Chinese Medicine Law was included in the first stage of the legislative plan for the Standing Committee of the National People's Congress in 2013, the venue rang. A thunderous applause.

The legislative process of Chinese medicine that has been bred for many years is expected to achieve a breakthrough this year. Zhang Boli, president of the Chinese Academy of Sciences of Traditional Chinese Medicine, revealed that the draft of the Chinese Medicine Law was last revised in May this year and will be approved by the State Council’s executive meeting in July and then submitted to the Standing Committee of the National People's Congress for consideration. According to the conventional law, the draft law must be approved by the third reading. Zhang Bolui expects that the Chinese Medicine Law will complete the first reading by the Standing Committee of the National People's Congress before December 31 this year.

Zhang Boli introduced: “Two weeks ago, the drafting group underwent the final revision meeting. The core contents of concern for the Chinese medicine community are basically covered by the draft. The initiatives that are close to Chinese medicine and promote the development of Chinese medicine are very detailed. If it is finally passed, it will be a law that will fundamentally promote the rapid development of Chinese medicine."

Related concept stocks include: Guizhou Braun, Tongrentang, Yunnan Baiyao, Qianjin Pharmaceutical, Kangmei Pharmaceutical, Jiangcai, Dong'e Ejiao, Zhejiang Zhenyuan, Jiuzhitang, Kunming Pharmaceuticals, Yiwei Pharmaceutical, Qizheng Tibetan Medicine.